ph+ Acute Lymphoblastic Leukemia Clinical Trials in Chicago, Illinois

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)